Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. SK bioscience Co.,Ltd.
  6. Summary
    A302440   KR7302440003

SK BIOSCIENCE CO.,LTD.

(A302440)
  Report
End-of-day quote Korea Stock Exchange  -  2023-03-21
71200.00 KRW   +0.99%
02/13SK Bioscience's Q4 Profit Plunges 85%
MT
02/13South Korean Stocks Close Lower as Investors Look Forward to US CPI Data; SK Hynix Loses 3%
MT
02/09SK Biopharmaceuticals Swings to Loss in Q4
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
03/20/2023 03/21/2023 03/22/2023 03/23/2023 03/24/2023 Date
71500 70500 71200 70100 69800 Last
301900 116921 150981 146583 144018 Volume
+2.58% -1.40% +0.99% -1.54% -0.43% Change
Estimated financial data (e)
Sales 2022 512 B 0,39 B 0,39 B
Net income 2022 150 B 0,12 B 0,12 B
Net cash position 2022 1 511 B 1,16 B 1,16 B
P/E ratio 2022 35,7x
Yield 2022 -
Sales 2023 325 B 0,25 B 0,25 B
Net income 2023 67,3 B 0,05 B 0,05 B
Net cash position 2023 1 324 B 1,02 B 1,02 B
P/E ratio 2023 79,6x
Yield 2023 -
Capitalization 5 360 B 4 128 M 4 128 M
EV / Sales 2022 7,51x
EV / Sales 2023 12,4x
Nbr of Employees -
Free-Float 30,5%
More Financials
Company
SK Bioscience Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biological products. The Company's main products include vaccines such as SKYCellflu and Rotatech. The Company also sells infusion solutions. In addition, the Company engages in technology export business. The Company sells its products in domestic and overseas markets. 
Read more
Sector
Pharmaceuticals
Calendar
05/12Earnings Release
More about the company
Ratings of SK bioscience Co.,Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about SK BIOSCIENCE CO.,LTD.
02/13SK Bioscience's Q4 Profit Plunges 85%
MT
02/13South Korean Stocks Close Lower as Investors Look Forward to US CPI Data; SK Hynix Lose..
MT
02/09SK Biopharmaceuticals Swings to Loss in Q4
MT
02/08SK Bioscience to Establish Songdo Global Research & Process Development Center
CI
01/27SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs
CI
01/18SK Bioscience Co.,Ltd. Receives Expanded Manufacturing and Marketing Approval from the ..
CI
01/09SK Bioscience Receives Biologics License Application Approval of the Skyzoster™ fr..
CI
01/09MarketScreener's World Press Review: January 9
MS
2022South Korean shares rebound from two-week low on upbeat Wall Street
RE
2022South Korean shares rise on Wall Street, platform stocks boost
RE
2022SK Bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
CI
2022SK bioscience Announces Executive Appointments
CI
2022Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsigh..
AQ
2022S.Korean shares end at over six-week low on Europe energy worries
RE
2022Sk Bioscience : Material Business Matters Related to Investment Decisions (Approval of cha..
PU
More news
News in other languages on SK BIOSCIENCE CO.,LTD.
02/13Le bénéfice du quatrième trimestre de SK Bioscience plonge de 85 %.
02/13Les actions sud-coréennes clôturent en baisse alors que les investisseurs attendent les..
02/104 minutos de mercados : Febrero 10-2023
02/094 minutos de mercados : Febrero 9-2023
02/09SK Biopharmaceuticals subit une perte au quatrième trimestre
More news
ETFs positioned on SK BIOSCIENCE CO.,LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck Global Healthcare Leaders ETF - AUD1.65%0.10%-NC
KraneShares Emerging Market Healthcare Inde...0.92%-0.10%NC
HAN-GINS Indxx Healthcare Megatrend Equal W...0.89%-4.37%-NC
Xtrackers MSCI Korea 1C - USD0.18%1.37%-NC
HSBC MSCI KOREA CAPPED - USD0.18%4.96%-Korea
More ETFs positioned on SK BIOSCIENCE CO.,LTD.
Chart SK BIOSCIENCE CO.,LTD.
Duration : Period :
SK bioscience Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SK BIOSCIENCE CO.,LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 69 800,00 KRW
Average target price 67 100,00 KRW
Spread / Average Target -3,87%
EPS Revisions
Managers and Directors
Jae-Yong An Chief Executive Officer & Director
Yong-Sung Choi Executive Board Member & Head-Finance
Hun Kim Chief Technology Officer & Director
Jong-Gu Park Executive Board Member & Head-Technology Support
Sally Choe Head-Global Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
SK BIOSCIENCE CO.,LTD.-3.13%4 211
CSL LIMITED0.15%93 458
SAMSUNG BIOLOGICS CO.,LTD.-1.34%44 439
BIOGEN INC.-4.24%38 313
WUXI BIOLOGICS (CAYMAN) INC.-15.29%27 312
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-0.36%20 262
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer